QuickView for clinical protocols (compound)

Name:	AC protocol + bevacizumab
Description:	Part of clinical trial NCT00408408 where a subset of patients were given docetaxel chemotherapy followed by AC (Adriamycin=doxorubicin and Cytoxan=cyclophosphamide) protocol in the presence of bevacizumab. http://clinicaltrials.gov/show/NCT00408408 http://www.cancer.gov/clinicaltrials/search/view?cdrid=515432&version=HealthProfessional http://www.nejm.org/doi/full/10.1056/NEJMoa1111097#t=article